Design Therapeutics (DSGN) Current Assets (2020 - 2021)
Design Therapeutics' Current Assets history spans 2 years, with the latest figure at $395.3 million for Q3 2021.
- For Q3 2021, Current Assets changed N/A year-over-year to $395.3 million; the TTM value through Sep 2021 reached $395.3 million, changed N/A, while the annual FY2020 figure was $36.2 million, N/A changed from the prior year.
- Current Assets for Q3 2021 was $395.3 million at Design Therapeutics, down from $404.9 million in the prior quarter.
- Across five years, Current Assets topped out at $411.8 million in Q1 2021 and bottomed at $36.2 million in Q4 2020.